The Mass General Department of Psychiatry encompasses more than 60 specialty integrated clinical and research programs. Our wide-ranging research portfolio spans clinical and basic research covering virtually every major psychiatric disorder, as well as the psychiatric consequences of medical illness.
These initiatives have led to notable expansions in genetics, neuroimaging and basic neuroscience, and this model of cross-talk between clinical care and science has consistently led to research advances that inform and advance clinical care.
Hypoactive Delirium: Differential Diagnosis, Evaluation, and Treatment.
Rosen JH, Bieber E, Matta SE, Sayde GE, Fedotova NO, deVries J, Rafferty M, Stern TA. Prim Care Companion CNS Disord. 2024 Feb 8; 26(1):23f03602.
The Evaluation and Treatment of Somatic Symptom Disorder in Primary Care Practices.
Tuttle MC, Ciampa DJ, Godena E, Kim BK, Sakmar KA, Vanwort-Meng L, Verma D, Stern TA, Yeung AS. Prim Care Companion CNS Disord. 2024 Jan 23;26(1):23f03549.
Introduction to a Special Issue: A Tribute to Dr. Joseph Biederman-Pioneering Insights in Child and Adult Psychiatry and Psychology.
Goldstein S, Faraone SV, Wilens TE, Wozniak JR, Surman CB, Gagan J, Spencer TJ. J Atten Disord. 2024 Jan 30:10870547231225007.
Improving multimodal physical function in adults with heterogeneous chronic pain; Protocol for a multisite feasibility RCT.
Hooker JE, Brewer JR, McDermott KA, Kanaya M, Somers TJ, Keefe F, Kelleher S, Fisher HM, Burns J, Jeddi RW, Kulich R, Polykoff G, Parker RA; THRIVE Study Team; Greenberg J, Vranceanu AM. Contemp Clin Trials. 2024 Jan 28;138:107462.
Contingency management is associated with positive changes in attitudes and reductions in cannabis use even after discontinuation of incentives among non-treatment seeking youth.
Cooke ME, Knoll SJ, Streck JM, Potter K, Lamberth E, Rychik N, Gilman JM, Evins AE, Schuster RM. Drug Alcohol Depend. 2024 Jan 20;256:111096.
Effect of multivitamin-mineral supplementation versus placebo on cognitive function: results from the clinic subcohort of the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial and meta-analysis of 3 cognitive studies within COSMOS.
Vyas CM, Manson JE, Sesso HD, Cook NR, Rist PM, Weinberg A, Moorthy MV, Baker LD, Espeland MA, Yeung LK, Brickman AM, Okereke OI. Am J Clin Nutr. 2024 Jan 18:S0002-9165(23)66342-7.
Changes in weight among individuals with psychiatric conditions or socioeconomic disadvantage assigned to smoke very low nicotine content cigarettes.
Harfmann RF, Heil SH, Bunn JY, Snell LM, Tidey JW, Sigmon SC, Gaalema DE, Lee DC, Streck JM, Bergeria CL, Davis DR, Plucinski S, Higgins ST. Exp Clin Psychopharmacol. 2024 Jan 18.
An Inpatient Protocol for the Treatment of Methamphetamine Withdrawal in Patients with and without Opioid Use Disorder.
Wilens TE, Wilson RLH, Beltrame L, Taylor A, O’Connell J. J Addict Med. 2024 Jan 16.
Association Between Subjective Cognitive Decline and Twice-Weekly Muscle-Strengthening Activities in Middle-Aged and Older US Adults: An Analysis of the 2019 Behavioral Risk Factor Surveillance System.
Schroeder MW, Waring ME, Fowler NR, Mace RA, Pagoto SL. Am J Health Promot. 2024 Jan 16:8901171231224517.
Minimal clinically important difference in the World Health Organization Quality of Life Brief (WHOQOL-BREF) for adults with neurofibromatosis.
Pietrzykowski MO, Vranceanu AM, Macklin EA, Mace RA. Qual Life Res. 2024 Jan 12.
Is Early Onset of Nonmedical Prescription Stimulant Use Associated With Cocaine Use During Adolescence? Results From a National Study.
McCabe SE, Schepis TS, Schulenberg JE, Wilens TE, Veliz PT. Subst Use Addctn J. 2024 Jan 4:29767342231219139.
Treating Executive Function in Youth With Attention Deficit Hyperactivity Disorder: A Review of Pharmacological and Non-Pharmacological Interventions.
Wilens TE, Stone M, Lanni S, Berger A, Wilson RLH, Lydston M, Surman CB. J Atten Disord. 2024 Jan 4:10870547231218925.
Medication Treatment for Youth in Substance Use Disorder Residential Treatment.
Yule AM, Mail V, Butler R, Wilens TE. J Atten Disord. 2024 Jan 3:10870547231218948.
Mutual Mistrust: The Multilayered Experiences at the Intersection of Healthcare and Early Parenting Among Mothers With Opioid Use Disorder.
Schiff DM, Muftu S, MacMillan KDL, Work EC, Hoeppner BB, Greenfield SF, Schwartz L, Chaiyachati B, Wilens TE, Bernstein JA. J Addict Med. 2024 Jan-Feb 01;18(1):55-61.
Genetic Liability to Posttraumatic Stress Disorder Symptoms and Its Association With Cardiometabolic and Respiratory Outcomes.
Pathak GA, Singh K, Choi KW, Fang Y, Kouakou MR, Lee YH, Zhou X, Fritsche LG, Wendt FR, Davis LK, Polimanti R. JAMA Psychiatry. 2024 Jan 1;81(1):34-44.
Alternative combusted tobacco product and multiple tobacco product use among individuals with serious mental illness enrolled in a large pragmatic randomized controlled trial.
Streck JM, Potter K, Pachas G, Cather C, Nielsen L, Eden Evins A. Addict Behav. 2024 Jan;148:107844.
Medications for Opioid Use Disorder for Youth: Patient, Caregiver, and Clinician Perspectives.
Buchholz C, Bell LA, Adatia S, Bagley SM, Wilens TE, Nurani A, Hadland SE. J Adolesc Health. 2024 Feb; 74(2):320-326.
Do ADHD Treatments Improve Executive Behavior Beyond Core ADHD Symptoms in Adults? Evidence From Systematic Analysis of Clinical Trials.
Surman CBH, Walsh DM. J Clin Pharmacol. 2023 Jun;63(6):640-653.
Assessing the presence and motivations of orthorexia nervosa among athletes and adults with eating disorders: a cross-sectional study.
Foyster M, Sultan N, Tonkovic M, Govus A, Burton-Murray H, Tuck CJ, Biesiekierski JR. Eat Weight Disord. 2023 Dec 9;28(1):101.
